Savaria Co. (TSE:SIS – Get Free Report) has been given an average recommendation of “Buy” by the six analysts that are covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued a report on the stock in the last year is C$26.67.
A number of research analysts recently commented on SIS shares. Scotiabank upped their price objective on Savaria from C$25.00 to C$26.00 in a research note on Monday, November 10th. National Bankshares increased their price objective on shares of Savaria from C$26.00 to C$30.00 in a report on Monday, December 22nd. TD Securities lifted their price objective on shares of Savaria from C$24.00 to C$27.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Finally, Stifel Nicolaus upped their target price on shares of Savaria from C$26.00 to C$28.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th.
View Our Latest Stock Analysis on SIS
Savaria Price Performance
Savaria (TSE:SIS – Get Free Report) last issued its earnings results on Wednesday, November 5th. The company reported C$0.32 EPS for the quarter. The company had revenue of C$224.77 million during the quarter. Savaria had a return on equity of 8.24% and a net margin of 5.34%. On average, sell-side analysts anticipate that Savaria will post 1.2048518 EPS for the current year.
About Savaria
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
See Also
- Five stocks we like better than Savaria
- Trade this between 9:30 and 10:45 am EST
- The $650 Million Bet on AI’s Future
- The gold chart Wall Street is terrified of…
- The buying spree that no one is talking about
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
